The introduction of new molecules based on complex chemistry has created growth opportunities for the company which caters to the agrochemicals and pharmaceuticals sectors. The company is in the process of launching 10 new molecules each of which may add about ₹15 crore annually to the top line. The company is expected to report ₹150 crore of incremental revenue in FY24. The total new molecule count so far has reached 58 at the end of September.
Anupam Rasayan bags order worth Rs 1,100 crore ANI | Updated: Apr 28, 2021 15:15 IST
Mumbai (Maharashtra) [India], Apr 28 (ANI): Surat-based speciality chemicals companyAnupam Rasayan said on Wednesday it has received a letter of intent worth Rs 1,100 crore from one of the top 10 multinational life sciences company.
The company will provide multiple products in life sciences related specialty chemicals for the next five years. Securing order from a leading multinational company in light of prevailing global uncertainty is a testament to our R&D processes, latest technology, infrastructure and quality of our existing products, said Managing Director Anand Desai.
The company makes products for more than 53 domestic and international customers, including 17 multinationals.
Balaji Amines stock rises 20% post Q3 earnings
Balaji Amines share has risen 24% in one week, 25% in one month and 248% in one year. Year-to-date, the stock has risen 55%
BusinessToday.In | February 9, 2021 | Updated 13:53 IST
Balaji Amines stock has risen 19.47% returns in the last 2 days
Share of Balaji Amines zoomed 20% to hit a new high of Rs 1,514 in Tuesday s early session after the firm s profit rose 162% to Rs 70.16 crore in the October-December quarter (Q3FY21) against a profit of Rs 26.73 crore in the year-ago quarter.
Balaji Amines stock has risen 19.47% returns in the last 2 days. Balaji Amines stock price opened with a gain of 13.44% today at Rs 1435.30 and later touched an intraday high of Rs 1514, rising 19.66% on BSE.